Vancomycin-Associated Leukocytoclastic Vasculitis
Joint Authors
Marschall, Jonas
Pongruangporn, Makhawadee
Lu, Dongsi
Ritchie, David J.
Source
Case Reports in Infectious Diseases
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-30
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Vancomycin is U.S.
Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics.
Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published.
We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin.
Skin biopsy revealed leukocytoclastic vasculitis.
American Psychological Association (APA)
Pongruangporn, Makhawadee& Ritchie, David J.& Lu, Dongsi& Marschall, Jonas. 2011. Vancomycin-Associated Leukocytoclastic Vasculitis. Case Reports in Infectious Diseases،Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-465410
Modern Language Association (MLA)
Pongruangporn, Makhawadee…[et al.]. Vancomycin-Associated Leukocytoclastic Vasculitis. Case Reports in Infectious Diseases No. 2011 (2011), pp.1-3.
https://search.emarefa.net/detail/BIM-465410
American Medical Association (AMA)
Pongruangporn, Makhawadee& Ritchie, David J.& Lu, Dongsi& Marschall, Jonas. Vancomycin-Associated Leukocytoclastic Vasculitis. Case Reports in Infectious Diseases. 2011. Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-465410
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-465410
